Autori: Milosavljevic Milos N
Naslov | Reslizumab versus placebo for poorly controlled, severe eosinophilic asthma: meta-analysis (Article) |
Autori | Milosavljevic Milos N Jankovic Slobodan M Pejcic Ana V Milovanovic Jasmina R Opancina Valentina D Kostic Marina J |
Info | VOJNOSANITETSKI PREGLED, (2018), vol. 75 br. 9, str. 884-896 |
Projekat | Serbian Ministry of Education, Science and Techonological Development [175007] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Risk factors for potential clopidogrel drug-drug interactions in stroke patients (Meeting Abstract) |
Autori | Aleksic Dejan Z Toncev Gordana L Miletic-Drakulic Svetlana D Milosavljevic Milos N Stefanovic Srdjan M Jankovic Slobodan M |
Info | CEREBROVASCULAR DISEASES, (2018), vol. 45 br. , Suppl. 1, str. 101-102 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Risk factors for potential drug-drug interactions in intensive care unit patients (Article) |
Autori | Jankovic Slobodan M Pejcic Ana V Milosavljevic Milos N Opancina Valentina D Pesic Nikola V Nedeljkovic Tamara T Babic Goran M |
Info | JOURNAL OF CRITICAL CARE, (2018), vol. 43 br. , str. 1-6 |
Projekat | bilateral scientific project between Serbia and Montenegro entitled "Risk factors for DDIs in tertiary care hospitals" |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Evaluation of brivaracetam: a new drug to treat epilepsy (Review) |
Autori | Milovanovic Jasmina R Jankovic Slobodan M Pejcic Ana V Milosavljevic Milos N Opancina Valentina D Radonjic Vesela B Protrka Zoran M Kostic Marina J |
Info | EXPERT OPINION ON PHARMACOTHERAPY, (2017), vol. 18 br. 13, str. 1381-1389 |
Projekat | Serbian Ministry of Education, Science and Technological Development [175007] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|